Researchers identify potential new drug target for chronic leukaemia

Researchers at the University of California, San Diego (UCSD) and the Moores UCSD Cancer Centre have discovered what could be a novel drug target for an often difficult-to-treat form of leukaemia. The investigators have identified a unique 'signature' or pattern of a specific family of enzymes in patients with chronic lymphocytic leukaemia (CLL), the most common form of adult leukaemia...

Read the whole article on

More from